Source: International Congress 2016 – New genomic targets in pulmonary disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Prakash Chelladurai ( Bad Nauheim, Germany), Prakash Chelladurai, Swati Dabral, Carsten Künne, Shobha Rani Basineni, Mario Schmoranzer, Christine Weber, René Reiner Nötzold, Florian Finkernagel, Mario Looso, Werner Seeger, Uta-Maria Bauer, Soni Savai Pullamsetti. LSC Abstract – Epigenome-wide mapping of histone modification landscape in human pulmonary arterial hypertension. Eur Respir J 2016; 48: Suppl. 60, 1780

Member's Comments

No comment yet.

Related content which might interest you: Epigenome-wide mapping of histone modification landscape in human pulmonary arterial hypertension Source: ERS Lung Science Conference 2016 Year: 2016 H3K27 histone lysine methylation as potential therapeutic target in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Implication of the histone methyltransferase EZH2 in pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 LSC Abstract – Histone deacetylase 7 mediated metabolic remodeling: A new crosslink between pulmonary hypertension and cancer Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Proteomic profiling identifies an exercise signature in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 A new molecular genetic diagnostic approach for pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives Source: Eur Respir Rev 2016; 25: 135-140 Year: 2016 Multi-omic profiling in pulmonary arterial hypertension Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Analysis of BMPR2 gene expression in B-lymphocytes of pulmonary arterial hypertension patients Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Epigenetic signature of right ventricular failure in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Mutational and epigenetic analysis of the promoter region of BMPR2 gene in patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Functional analysis of the 5´UTR region of BMPR2 gene in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006 Integrating haemodynamics identifies an extreme pulmonary hypertension phenotype Source: Eur Respir J, 58 (2) 2004625; 10.1183/13993003.04625-2020 Year: 2021 Prevention of fetal programming of pulmonary vascular dysfunction by a histone deacetylase inhibitor Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Functional characterization of BMPR2 gene in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 First identification of Krüppel-like factor 2 mutation in heritable pulmonary arterial hypertension Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017